Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Psychotherapeutic and psychosocial interventions for managing stress in multiple sclerosis: the contribution of mindfulness-based interventions.
Assessing the impact of multiple sclerosis disease activity and daclizumab HYP treatment on patient-reported outcomes: Results from the SELECT trial.
Cytochrome P450 3A4 is the major enzyme responsible for the metabolism of laquinimod, a novel immunomodulator.
Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis.
Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis.
Psoriasis during natalizumab treatment for multiple sclerosis.
PEGylated interferon beta-1a in the treatment of multiple sclerosis - an update.
The mammalian Na+/H+ exchanger gene family--initial structure/function studies.
High risk of MS in Iranian immigrants in Gothenburg, Sweden.
Assessment of cerebral venous return by a novel plethysmography method.
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial.
Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.
Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.
Characterization of human platelet binding of recombinant T cell receptor ligand.
The impact of environmental infections (parasites) on MS activity.
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial.
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Momenta Pharmaceuticals Announces Launch of Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis.
Raltegravir (Isentress) pilot study in relapsing multiple sclerosis (INSPIRE)
Solodyn
Activities of daily living: evaluation and treatment in persons with multiple sclerosis.
Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica.
Birth outcomes of pregnancies fathered by men with multiple sclerosis.
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.

Pages